uniQure Announces Second Quarter 2026 Financial Results and Provides Company Update
~ U.S. and U.K. regulatory submissions for AMT-130 for Huntington’s disease on track as planned for the third quarter of 2026 ~
Covered in this story
What has happened since
- American Tower is up 2.4% since this was published, 83 days ago.
Price move measured from the close nearest publication to the latest quote.
Call it yourself
No calls on $AMT yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on American Tower →Summary aggregated from GlobeNewswire's public RSS feed. The full reporting belongs to GlobeNewswire — please read it on their site.